ISIS PHARMACEUTICALS INC (ISIS) is a publicly traded company in the Unknown sector. Across all available filings, 14 corporate insiders have executed 1000 transactions totaling $99.3M, demonstrating a bearish sentiment with -$99.3M in net insider flow. The most recent transaction on Dec 16, 2015 involved a transaction of 3,909 shares valued at $56.6K.
No significant insider buying has been recorded for ISIS in the recent period.
No significant insider selling has been recorded for ISIS in the recent period.
Based on recent SEC filings, insider sentiment for ISIS is bearish with an Insider Alignment Score of 0/100 and a net flow of -$99.3M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at ISIS PHARMACEUTICALS INC (ISIS) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 14 insiders are actively trading ISIS stock, having executed 1000 transactions in the past 90 days. The most active insider is Stanley T. Crooke (Executive), who has made 247 transactions totaling $50.1M.
Get notified when executives and directors at ISIS file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 16, 2015 | Frank Bennett C. | Executive | Option Exercise | 3,909 | $14.47 | $56.6K | |
| Dec 16, 2015 | Frank Bennett C. | Executive | Sale | 3,909 | $58.85 | $230.0K | |
| Dec 15, 2015 | Frank Bennett C. | Executive | Option Exercise | 4,000 | $14.47 | $57.9K | |
| Dec 15, 2015 | Frank Bennett C. | Executive | Sale | 4,000 | $56.00 | $224.0K | |
| Dec 1, 2015 | R. O'neil Patrick | Executive | Sale | 1,000 | $61.50 | $61.5K | |
| Dec 1, 2015 | R. O'neil Patrick | Executive | Option Exercise | 1,000 | $7.25 | $7.3K | |
| Nov 11, 2015 | Klein Joseph III | Executive | Sale | 3,750 | $64.18 | $240.7K | |
| Nov 11, 2015 | Klein Joseph III | Executive | Option Exercise | 3,125 | $12.94 | $40.4K | |
| Nov 11, 2015 | Klein Joseph III | Executive | Sale | 3,125 | $64.18 | $200.6K | |
| Nov 11, 2015 | Klein Joseph III | Executive | Option Exercise | 3,750 | $9.30 | $34.9K | |
| Nov 10, 2015 | Frank Bennett C. | Executive | Option Exercise | 5,000 | $14.47 | $72.3K | |
| Nov 10, 2015 | Frank Bennett C. | Executive | Sale | 5,000 | $64.00 | $320.0K | |
| Nov 6, 2015 | Frank Bennett C. | Executive | Sale | 5,000 | $56.00 | $280.0K | |
| Nov 6, 2015 | Frank Bennett C. | Executive | Option Exercise | 5,000 | $14.47 | $72.3K | |
| Nov 3, 2015 | R. O'neil Patrick | Executive | Sale | 1,000 | $51.95 | $52.0K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 481 | $99.3M | 76.6% |
Exercise(M) | 482 | $30.1M | 23.2% |
Other(J) | 36 | $218.9K | 0.2% |
Gift(G) | 1 | $0 | 0.0% |
Insider selling pressure at ISIS PHARMACEUTICALS INC has increased, with 14 insiders executing 1000 transactions across all time. Total sales of $99.3M significantly outpace purchases of $0, resulting in a net outflow of $99.3M. This selling activity appears largely discretionary, which may warrant closer attention from investors.